These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3062771)

  • 1. [Endothelium-derived relaxing factor(s): endogenous nitrates in the circulation?].
    Lüscher TF; Yang Z; Diederich D; Schneider K; von Segesser L; Siebenmann R; Stulz P; Bühler FR
    Schweiz Med Wochenschr; 1988 Nov; 118(46):1724-9. PubMed ID: 3062771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived relaxing and contracting factors.
    Vanhoutte PM; Eber B
    Wien Klin Wochenschr; 1991; 103(14):405-11. PubMed ID: 1926867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E
    Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived serotonin, the endothelium, and cardiovascular disease.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S6-12. PubMed ID: 1717775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of thrombocyte aggregation and adhesion by endothelium-derived relaxant factor (EDRF) and their pathophysiologic significance].
    Bassenge E; Busse R; Pohl U
    Z Kardiol; 1989; 78 Suppl 6():54-8. PubMed ID: 2515672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
    McHugh J; Cheek DJ
    Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial functions in cardiovascular diseases].
    Mügge A; Förstermann U; Lichtlen PR
    Z Kardiol; 1989 Mar; 78(3):147-60. PubMed ID: 2652905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and exogenous nitrates.
    Anggård EE
    Acta Anaesthesiol Scand Suppl; 1992; 97():7-10. PubMed ID: 1557942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial dysfunction and vascular pathology].
    Vanhoutte PM
    Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endothelial dysfunction and atherosclerosis].
    Vanhoutte PM
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():9-19. PubMed ID: 9515109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous nitrates--implications for treatment and prevention.
    Anggård EE
    Eur Heart J; 1991 May; 12 Suppl A():5-8. PubMed ID: 1874272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
    Bauer V; Sotníková R
    Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.
    Cappelli-Bigazzi M; Battaglia C; Pannain S; Chiariello M; Ambrosio G
    J Mol Cell Cardiol; 1997 Mar; 29(3):871-9. PubMed ID: 9152848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion.
    Lüscher TF; Yang ZH; Diederich D; Bühler FR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S63-9. PubMed ID: 2478827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.